BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8462025)

  • 1. A model for others: a strategy for improving diagnosis and therapy of human malignancies using monoclonal antibodies targeting TAG-72 oncofetal antigen.
    Larson SM
    Cancer Invest; 1993; 11(2):235-8. PubMed ID: 8462025
    [No Abstract]   [Full Text] [Related]  

  • 2. A simple method to determine the immunoreactivity of radiolabelled monoclonal antibodies to the TAG-72 antigen.
    Ngai WM; Reilly RM
    Appl Radiat Isot; 1993 Sep; 44(9):1193-7. PubMed ID: 8401449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary antibodies as tools to improve tumor to non tumor ratio at radioimmunolocalisation and radioimmunotherapy.
    Ullén A; Ahlström KR; Heitala S; Nilsson B; Arlestig L; Stigbrand T
    Acta Oncol; 1996; 35(3):281-5. PubMed ID: 8679257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the pretargeting approach to image and treat tumours.
    Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
    Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretargeting strategies for radio-immunoguided tumour localisation and therapy.
    Stoldt HS; Aftab F; Chinol M; Paganelli G; Luca F; Testori A; Geraghty JG
    Eur J Cancer; 1997 Feb; 33(2):186-92. PubMed ID: 9135486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy of solid tumors: from fairytale to reality.
    Adams GP; Weiner LM
    Cancer Biother Radiopharm; 2001 Feb; 16(1):9-11. PubMed ID: 11279802
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioimmunodiagnosis and therapy.
    Verhaar-Langereis MJ; Zonnenberg BA; de Klerk JM; Blijham GH
    Cancer Treat Rev; 2000 Feb; 26(1):3-10. PubMed ID: 10660488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4th Scandinavian Symposium on Radiolabeled Monoclonal Antibodies in Diagnosis and Therapy of Cancer. Lillehammer, Norway, January 15-17, 1995.
    Acta Oncol; 1996; 35(3):257-390. PubMed ID: 8679253
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic applications and therapeutic approaches with different preparations of anti-CEA antibodies.
    Bischof Delaloye A; Delaloye B
    Int J Biol Markers; 1992; 7(3):193-7. PubMed ID: 1431345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49.
    Kostakoglu L; Divgi CR; Hilton S; Cordon-Cardo C; Scott AM; Kalaigian H; Finn RD; Schlom J; Larson SM
    Cancer Invest; 1994; 12(6):551-8. PubMed ID: 7994589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioimmunotargeting: diagnosis and therapeutic use].
    Vuillez JP
    Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer.
    Divgi CR
    Oncology (Williston Park); 1996 Jun; 10(6):939-53; discussion 954, 957-8. PubMed ID: 8823804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
    Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
    Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies. An approach to diagnosis and treatment of micrometastases].
    Bier H
    HNO; 1994 May; 42(5):255-6. PubMed ID: 8050912
    [No Abstract]   [Full Text] [Related]  

  • 16. The current status of radiolabeled monoclonal antibodies for the diagnosis and treatment of human malignancies.
    Kuzel TM; Duda RB
    Compr Ther; 1992 Jun; 18(6):16-20. PubMed ID: 1511591
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
    Rogers BE; Roberson PL; Shen S; Khazaeli MB; Carpenter M; Yokoyama S; Brechbiel MW; LoBuglio AF; Buchsbaum DJ
    Cancer Biother Radiopharm; 2005 Oct; 20(5):502-13. PubMed ID: 16248766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: what ails solid tumor radioimmunotherapy?
    Divgi C
    Cancer Biother Radiopharm; 2006 Apr; 21(2):81-4. PubMed ID: 16706627
    [No Abstract]   [Full Text] [Related]  

  • 19. Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and 90Y-DOTA-biotin.
    Domingo RJ; Reilly RM
    Nucl Med Commun; 2000 Jan; 21(1):89-96. PubMed ID: 10717908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoscintigraphy and radioimmunotherapy in Cuba: experiences with labeled monoclonal antibodies for cancer diagnosis and treatment (1993-2013).
    Peña Y; Perera A; Batista JF
    MEDICC Rev; 2014; 16(3-4):55-60. PubMed ID: 25208121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.